Joseph W La Plume Charles River Laboratories International, Inc. (CRL) insider trading activity

Joseph W La Plume is EVP, Corp Strategy & Develop of CHARLES RIVER LABORATORIES INTERNATIONAL, INC.. Currently has a direct ownership of 22,521 shares of CRL, which is worth approximately $4.18 Million. The most recent transaction as insider was on Aug 08, 2024, when has been sold 1,780 shares (Common Stock) at a price of $199.36 per share, resulting in proceeds of $354,860. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 22.5K

0% 3M change

2.65% 12M change

Total Value Held $4.18 Million

Joseph W LaPlume Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Aug 08 2024	SELL Open market or private sale	$354,860 $199.36 p/Share	1,780 Reduced 7.32%	22,521 Common Stock
Jun 03 2024	SELL Bona fide gift	-	311 Reduced 1.26%	24,301 Common Stock
May 31 2024	BUY Grant, award, or other acquisition	-	2,111 Added 7.9%	24,612 Common Stock
May 29 2024	SELL Payment of exercise price or tax liability	$47,835 $214.51 p/Share	223 Reduced 0.98%	22,501 Common Stock
May 28 2024	SELL Payment of exercise price or tax liability	$27,151 $217.21 p/Share	125 Reduced 0.55%	22,724 Common Stock
May 27 2024	SELL Payment of exercise price or tax liability	$39,966 $217.21 p/Share	184 Reduced 0.8%	22,849 Common Stock
May 26 2024	SELL Payment of exercise price or tax liability	$52,782 $217.21 p/Share	243 Reduced 1.04%	23,033 Common Stock
May 10 2024	SELL Open market or private sale	$295,968 $226.97 p/Share	1,304 Reduced 5.31%	23,276 Common Stock
Feb 15 2024	SELL Open market or private sale	$200,223 $238.93 p/Share	838 Reduced 3.29%	24,620 Common Stock
Jan 29 2024	SELL Payment of exercise price or tax liability	$225,787 $220.28 p/Share	1,025 Reduced 3.87%	25,458 Common Stock
Jan 29 2024	BUY Grant, award, or other acquisition	-	3,350 Added 11.23%	26,483 Common Stock
Nov 30 2023	SELL Open market or private sale	$365,800 $197.73 p/Share	1,850 Reduced 7.41%	23,133 Common Stock
Nov 09 2023	SELL Open market or private sale	$1,581,517 $173.26 p/Share	9,128 Reduced 26.76%	24,983 Common Stock
Nov 09 2023	BUY Exercise of conversion of derivative security	$1,320,547 $144.67 p/Share	9,128 Added 21.11%	34,111 Common Stock
Aug 10 2023	SELL Open market or private sale	$151,564 $216.52 p/Share	700 Reduced 2.73%	24,983 Common Stock
May 29 2023	SELL Payment of exercise price or tax liability	$43,288 $194.12 p/Share	223 Reduced 0.86%	25,683 Common Stock
May 28 2023	SELL Payment of exercise price or tax liability	$24,265 $194.12 p/Share	125 Reduced 0.48%	25,906 Common Stock
May 27 2023	SELL Payment of exercise price or tax liability	$35,718 $194.12 p/Share	184 Reduced 0.7%	26,031 Common Stock
May 26 2023	BUY Grant, award, or other acquisition	-	2,189 Added 7.71%	26,215 Common Stock
May 15 2023	SELL Open market or private sale	$65,684 $190.39 p/Share	345 Reduced 1.42%	24,026 Common Stock
May 12 2023	SELL Open market or private sale	$185,614 $193.55 p/Share	959 Reduced 3.79%	24,371 Common Stock
Feb 22 2023	SELL Payment of exercise price or tax liability	$77,221 $243.6 p/Share	317 Reduced 1.24%	25,330 Common Stock
Jan 27 2023	SELL Payment of exercise price or tax liability	$796,629 $244.29 p/Share	3,261 Reduced 11.28%	25,647 Common Stock
Jan 27 2023	BUY Grant, award, or other acquisition	-	8,676 Added 23.08%	28,908 Common Stock
Dec 01 2022	SELL Open market or private sale	$1,436,320 $224.11 p/Share	6,409 Reduced 24.06%	20,232 Common Stock

JWL

Joseph W La Plume

EVP, Corp Strategy & Develop

Wilmington, MA

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells CRL shares.

Notify only if

Value

Insider Trading

Get notified when an Charles River Laboratories International, Inc. insider buys or sells CRL shares.

Notify only if

Operation

Value

Type

News

Receive news related to CHARLES RIVER LABORATORIES INTERNATIONAL, INC.

Track Activities on CRL

Account